BHB Supplement Shields Brain from Damage Caused by Saturated Fat Diets

Cognitive decline linked to poor diet is a growing global concern, with saturated fatty acids increasingly implicated in impairing memory and synaptic plasticity. This study investigated whether beta-hydroxybutyrate (BHB)—the dominant ketone body elevated during fasting and ketogenic diets—could protect against the neurological damage caused by saturated fat exposure, focusing specifically on AMPA-type glutamate receptors (AMPARs), which are central to synaptic strengthening and memory formation.

Using primary cortical and hippocampal neuron cultures, the researchers showed that palmitic acid (PA), a common saturated fat, significantly reduced surface levels of GluA1-containing AMPARs. In contrast, unsaturated fatty acids (oleic acid, DHA) and BHB at physiological concentrations (1–2 mM) increased surface AMPAR levels. Critically, co-treatment with BHB rescued the PA-induced loss of both GluA1 and GluA2 at synaptic sites marked by PSD95, and electrophysiological recordings confirmed that BHB restored AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs) suppressed by palmitate.

In acute hippocampal slice preparations, palmitate impaired input-output relationships, increased paired-pulse ratios (suggesting reduced presynaptic release), and blunted long-term potentiation (LTP) at Schaffer collateral–CA1 synapses. BHB treatment reversed all three deficits, restoring synaptic excitability and plasticity toward control levels without affecting baseline transmission on its own.

The in vivo component involved C57BL/6J mice fed either a standard chow diet or a saturated fatty acid-enriched diet (SFAD; 49% kcal from fat, ~7% from palmitic acid) for seven weeks starting at five weeks of age. Half of each dietary group received daily intragastric BHB (100 mg/kg) and half received vehicle. BHB supplementation fully prevented the SFAD-induced deficits in Novel Object Recognition (NORT) and Object Location (OLT) tests, which assess recognition and spatial memory respectively, without affecting locomotion or anxiety in the Open Field Test. Western blot analysis of hippocampal tissue confirmed that SFAD reduced GluA1 and GluA2 protein levels, and BHB supplementation partially restored these changes.

These results establish a mechanistic link between dietary saturated fat, impaired AMPAR trafficking, synaptic dysfunction, and cognitive decline—and demonstrate that BHB can intervene at each of these levels. The study positions BHB supplementation as a potentially accessible neuroprotective strategy for individuals unable or unwilling to adopt strict ketogenic or intermittent fasting protocols, particularly in the context of modern high-fat dietary patterns.